September 3, 2007
Prospector
Profile
07.1264
 
TraceGuard Technologies, Inc. NAICS 334519
330 Madison Avenue, 9th Floor New York, NY 10017 Description Explosive Detectors Mfg.
(866) 401-5969 Employees 579
http://www.safetyinsurance.com/ Revenue (mil) 0.0000
  Income (mil) -5.9670
  Assets (mil) 2.1620
  Liability (mil) 0.6810
  (for the year ended 2006-12-31)
 
Category: Loss/Deficit
 
Event: TraceGuard Technologies, Inc. reported a net loss of $1,858,942 for the second quarter ended June 30, 2007, compared to a net loss of $1,009,156 for the same quarter last year. For the six months ended June 30, 2007, the Company recorded a net loss of $3,752,176, more than double the $1,713,853 net loss reported during the first half of last year. As a result of its recurring losses, the Company has an accumulated deficit of $10,167,030 at June 30, 2007.
 
Intellectual Property: TraceGuard has obtained an exclusive, worldwide, perpetual license for two pending patents (PCT/IL03/00041 and PCT/IL2004/000011), which have been filed by Tracetrack Technology Ltd. in the USA and Western Europe. TraceGuard has since filed five patent applications and three provisional patents in the U.S. and other countries. These patents cover key aspects of its core technology. TraceGuard is in the process of preparing additional patent applications, in the United States and other countries, for additional technologies, which it has developed and is planning to develop. These additional technologies pertain to the use of its licensed proprietary technology in conjunction with its future products for the security market. [SEC Filing 10-KSB 03-30-07]
 
Description: The Company develops security technologies and solutions for explosives detection.
 
Officers: Dr. Ehud Ganani (Chair, Pres. & CEO); Dr. Fredy Ornath (Chief Scientist); David Ben-Yair (CFO); Gil Perlberg (VP); Jack Hornstein (Dir.); David Cohen (Dir.)
 
Auditor: Kesselman & Kesselman
 
Securities: Common Stock-Symbol TCGD.OB; OTC BB; 37,703,354 common shares outstanding as of August 9, 2007.
 
 
 
return to main page